期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Establishing 1H nuclear magnetic resonance based metabonomics fingerprinting profile for spinal cord injury: a pilot study 被引量:8
1
作者 JIANG Hua PENG Jin +5 位作者 ZHOU Zhi-yuar DUAN Yu CHEN Wei CAI Bin YANG Hao ZHANG Wei 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第17期2315-2319,共5页
Background Spinal cord injury (SCI) is a complex trauma that consists of multiple pathological mechanisms involving cytotoxic, oxidation stress and immune-endocrine. This study aimed to establish plasma metabonomics... Background Spinal cord injury (SCI) is a complex trauma that consists of multiple pathological mechanisms involving cytotoxic, oxidation stress and immune-endocrine. This study aimed to establish plasma metabonomics fingerprinting atlas for SCI using 1H nuclear magnetic resonance (NMR) based metabonomics methodology and principal component analysis techniques.Methods Nine Sprague-Dawley (SD) male rats were randomly divided into SCI, normal and sham-operation control groups. Plasma samples were collected for 1H NMR spectroscopy 3 days after operation. The NMR data were analyzed using principal component analysis technique with Matlab software.Results Metabonomics analysis was able to distinguish the three groups (SCI, normal control, sham-operation). The fingerprinting atlas indicated that, compared with those without SCI, the SCI group demonstrated the following characteristics with regard to second principal component: it is made up of fatty acids, myc-inositol, arginine, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), triglyceride (TG), glucose, and 3-methyl-histamine.Conclusions The data indicated that SCI results in several significant changes in plasma metabolism early on and that a metabonomics approach based on 1H NMR spectroscopy can provide a metabolic profile comprising several metabolite classes and allow for relative quantification of such changes. The results also provided support for further development and application of metabonomics technologies for studying SCI and for the utilization of multivariate models for classifying the extent of trauma within an individual. 展开更多
关键词 metabonomic spinal cord injury 1h nuclear magnetic resonance principal component analysis
原文传递
Fingerprinting Analysis of Rhizoma Chuanxiong of Commercial Types using ~1H Nuclear Magnetic Resonance Spectroscopy and High Performance Liquid Chromatography Method 被引量:13
2
作者 Hai-Lin Qin An-Jun Deng Guan-Hua Du Peng Wang Jin-Lan Zhang Zhi-Hong Li 《Journal of Integrative Plant Biology》 SCIE CAS CSCD 2009年第6期537-544,共8页
The ^1 H nuclear magnetic resonance (^1 H NMR) fingerprints of fractionated non-polar extracts (control substance for a plant drug (CSPD) A) from Rhizoma chuanxiong, the rhizomes of Ligusticum chuanxiong Hort., ... The ^1 H nuclear magnetic resonance (^1 H NMR) fingerprints of fractionated non-polar extracts (control substance for a plant drug (CSPD) A) from Rhizoma chuanxiong, the rhizomes of Ligusticum chuanxiong Hort., of seven specimens from different sources were measured on Fourier Transform (FT)-NMR spectrometer and assigned by comparing them with the ^1 H NMR spectra of the isolated pure compounds. The ^1 H NMR fingerprints showed exclusively characteristic resonance signals of the major special constituents of the plant. Although the differences in the relative intensity of the ^1H NMR signals due to a discrepancy in the ratio of the major constituents among these samples could be confirmed by high performance liquid chromatography analysis, the general features of the ^1H NMR fingerprint established for an authentic sample of the rhizomes of L. chuanxiong e. hibited exclusive data from those special compounds and can be used for authenticating L. Chuanxiong species. 展开更多
关键词 control substance for a plant drug A ^1 H nuclear magnetic resonance fingerprint high performance liquid chromatography Ligusticumchuanxiong phenylpropenoid phthalides.
原文传递
Prediction of Metabolic Disorders Using NMR-Based Metabolomics:The Shanghai Changfeng Study 被引量:3
3
作者 Qi Wu Qing-xia Huang +5 位作者 Hai-luan Zeng Shuai Ma Huan-dong Lin Ming-feng Xia Hui-ru Tang Xin Gao 《Phenomics》 2021年第4期186-198,共13页
A metabolically healthy status,whether obese or not,is a transient stage with the potential to develop into metabolic disor-ders during the course of life.We investigated the incidence of metabolic disorders in 1078 m... A metabolically healthy status,whether obese or not,is a transient stage with the potential to develop into metabolic disor-ders during the course of life.We investigated the incidence of metabolic disorders in 1078 metabolically healthy Chinese adults from the Shanghai Changfeng Study and looked for metabolites that discriminated the participants who would develop metabolic disorders in the future.Participants were divided into metabolically healthy overweight/obesity(MHO)and meta-bolically healthy normal weight(MHNW)groups according to their body mass index(BMI)and metabolic status.Their serum metabolomic profile was measured using a ^(1)H nuclear magnetic resonance spectrometer(^(1)H-NMR).The prevalence of diabetes,hypertriglyceridemia,hypercholesterolemia and metabolic syndrome was similar between the MHNW and MHO participants at baseline.After a median of 4.2 years of follow-up,more MHO participants became metabolically unhealthy than MHNW participants.However,a subgroup of MHO participants who remained metabolically healthy(MHO→MHO)had a similar prevalence of metabolic disorders as the MHNW participants at the follow-up examination,despite a signifi-cant reduction in their serum concentrations of high-density lipoprotein(HDL)and an elevation in valine,leucine,alanine and tyrosine.Further correlation analysis indicated that serum intermediate-density lipoprotein(IDL)and very low-density lipoprotein cholesterol(VLDL-CH)might be involved in the transition from metabolically healthy to unhealthy status and could be valuable to identify the MHNW and MHO with increased metabolic risks. 展开更多
关键词 Metabolically healthy normal weight(MHNW) Metabolically healthy overweight/obesity(MHO) ^(1)H nuclear magnetic resonance spectrometer(^(1)H-NMR) Metabolic disorders Very low-density lipoprotein cholesterol(VLDL-CH) Intermediate-density lipoprotein(IDL)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部